# Africa and Middle East Cardiovascular Epidemiological Study

> **NCT01243138** · — · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 4386 (actual)

## Conditions studied

- Obesity
- Smoking
- Dyslipidemia
- Diabetes Mellitus
- Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01243138
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 4386 (ACTUAL)
- **Last updated:** 2021-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01243138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01243138, "Africa and Middle East Cardiovascular Epidemiological Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01243138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*